Status:
RECRUITING
Cerebellar TMS and Satiety in Prader-Willi Syndrome
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Foundation for Prader-Willi Research
Conditions:
Prader-Willi Syndrome
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
This study uses a noninvasive technique called transcranial magnetic stimulation (TMS) to study hyperphagia and satiety in Prader-Willi syndrome. TMS is a noninvasive way of stimulating the brain, us...
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of Prader-Willi syndrome
Exclusion Criteria:
- contraindications for TMS or MRI including :
- history of neurological disorder
- history of head trauma resulting in loss of consciousness
- history of seizures or diagnosis of epilepsy or first degree relative family history of epilepsy
- metal in brain or skull
- implanted devices such as a pacemaker, medication pump, nerve stimulator or ventriculoperitoneal shunt claustrophobic in MRI
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05938543
Start Date
September 1 2023
End Date
October 1 2026
Last Update
December 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McLean Hospital
Belmont, Massachusetts, United States, 02478